|
Market Closed -
Euronext Paris
16:55:00 18/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 60.00 EUR | -2.83% |
|
-2.99% | +15.05% |
| 08-12 | Barclays Upgrades Arkema to Equalweight, Raises PT | MT |
| 07-30 | Arkema: A strong Q2 but limited visibility for H2 |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Specialty Chemicals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.41B | |||||
| 77.33B | |||||
| 37.39B | |||||
| 36.29B | |||||
| 24.33B | |||||
| 22.64B |
- Stock Market
- Stocks
- AKE Stock
- Charts Arkema
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
